While platelets might aid CD8+ T cells early in driving steatohepatitis, they might dampen tumor growth in advanced stages of NASH via recruitment of tumor-fighting T cells, however, this warrants further investigation [216]. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.